Literature DB >> 22070690

2,5-diketopiperazines as neuroprotective agents.

C Cornacchia1, I Cacciatore, L Baldassarre, A Mollica, F Feliciani, F Pinnen.   

Abstract

2,5-diketopiperazines are the simplest cyclic peptides found in nature, commonly biosynthesized from amino acids by different organisms, and represent a promising class of biologically active natural products. Their peculiar heterocyclic structure confers high stability against the proteolysis and constitutes a structural requirement for the active intestinal absorption. Furthermore, the diketopiperazine-based motif is considered as a novel brain shuttle for the delivery of drugs with limited ability to cross the blood-brain barrier (BBB) and can be proposed as an ideal candidate for the rational development of new therapeutic agents. Although these cyclic peptides have been known since the beginning of the 20th century, only recently have they attracted substantial interest with respect to the wide spectrum of their biological properties, including antitumor, antiviral, antifungal, antibacterial and antihyperglycemic activities. In addition to these, the most challenging function of the diketopiperazine derivatives is related with their remarkable neuroprotective and nootropic activity. The aim of the present paper is to provide an overview of the two major classes of diketopiperazines, the TRH-related and the unsaturated derivatives both characterized by a significant ability to protect against neurotoxicity in several experimental models. The neuroprotective profile of these compounds suggests that they may have a future utility in the therapy of neuronal degeneration in vivo, potentially through several different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22070690     DOI: 10.2174/138955712798868959

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  23 in total

1.  Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-κB pathway.

Authors:  Kiwan Kim; Na-Jeong Kim; So Young Kim; In Hwang Kim; Kun-Soo Kim; Gap Ryol Lee
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

2.  Synthesis and biological evaluation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines: synthetic methodology, enantioselective total synthesis of epicoccin G, 8,8'-epi-ent-rostratin B, gliotoxin, gliotoxin G, emethallicin E, and haematocin and discovery of new antiviral and antimalarial agents.

Authors:  K C Nicolaou; Min Lu; Sotirios Totokotsopoulos; Philipp Heretsch; Denis Giguère; Ya-Ping Sun; David Sarlah; Thu H Nguyen; Ian C Wolf; Donald F Smee; Craig W Day; Selina Bopp; Elizabeth A Winzeler
Journal:  J Am Chem Soc       Date:  2012-10-04       Impact factor: 15.419

Review 3.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 4.  A brief history of antibiotics and select advances in their synthesis.

Authors:  Kyriacos C Nicolaou; Stephan Rigol
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

5.  Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.

Authors:  Carolyn L Fisher; Ross J Resnick; Soumya De; Lucila A Acevedo; Kun Ping Lu; Frank C Schroeder; Linda K Nicholson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  General approach for preparing epidithiodioxopiperazines from trioxopiperazine precursors: enantioselective total syntheses of (+)- and (-)-gliocladine C, (+)-leptosin D, (+)-T988C, (+)-bionectin A, and (+)-gliocladin A.

Authors:  John E DeLorbe; David Horne; Richard Jove; Steven M Mennen; Sangkil Nam; Fang-Li Zhang; Larry E Overman
Journal:  J Am Chem Soc       Date:  2013-03-01       Impact factor: 15.419

Review 7.  Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems.

Authors:  Ivana Cacciatore; Leonardo Baldassarre; Erika Fornasari; Adriano Mollica; Francesco Pinnen
Journal:  Oxid Med Cell Longev       Date:  2012-06-03       Impact factor: 6.543

8.  New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death.

Authors:  Yoshiyuki Hirata; Tsutomu Sasaki; Hideaki Kanki; Chi-Jing Choong; Kumiko Nishiyama; Genki Kubo; Ayana Hotei; Masahiko Taniguchi; Hideki Mochizuki; Shinichi Uesato
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

Review 9.  Diketopiperazine Gels: New Horizons from the Self-Assembly of Cyclic Dipeptides.

Authors:  Marco Scarel; Silvia Marchesan
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

10.  A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells.

Authors:  Ivana Cacciatore; Erika Fornasari; Leonardo Baldassarre; Catia Cornacchia; Stefania Fulle; Ester Sara Di Filippo; Tiziana Pietrangelo; Francesco Pinnen
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.